Clinical Trials Directory

Trials / Terminated

TerminatedNCT01614925

Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain

A Randomized, Controlled, Multicenter Clinical Study Evaluating the Outcomes of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain

Status
Terminated
Phase
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Institut Straumann AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to demonstrate that in supra-alveolar-type defects (i.e., defects displaying a predominately horizontal pattern of bone loss), periodontal surgery with the additional use of Straumann® Emdogain will result in significantly higher Clinical Attachment Level (CAL) gain compared to periodontal surgery without Straumann® Emdogain.

Detailed description

The following secondary endpoints will be evaluated during the study: * Change in Gingival Margin (GM) at 12 months after surgery compared to baseline * Change in Probing Pocket Depth (PPD) at 12 months after surgery compared to baseline * Comparison of early wound healing index (EHI) at 4 weeks after surgery between treatment groups * Comparison of post-surgical pain at 4 weeks after surgery between treatment groups * Change in Bleeding on Probing (BoP) at 12 months after surgery compared to baseline * Change in root dentin hypersensitivity at 12 months after surgery compared to baseline * Change in full mouth plaque index (PI) at 12 months after surgery compared to baseline

Conditions

Interventions

TypeNameDescription
DEVICEEmdogainPeriodontal surgery with the additional use of Straumann® Emdogain
PROCEDUREPeriodontal surgeryPeriodontal surgery alone

Timeline

Start date
2012-11-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2012-06-08
Last updated
2020-12-01
Results posted
2020-12-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01614925. Inclusion in this directory is not an endorsement.